Position in SYRE
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$6,518,966
+$2,524,180 QoQ
Shares Held
129,242
+6.0% QoQ
Ownership
0.149%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 55%
Shared 0%
None 45%
Common Shares in SYRE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DEUTSCHE BANK AG\ holds $2,973,536,998 across 248 Biotechnology names. SYRE ranks #56 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,537,736 | $686,660,626 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
625,388 | $483,199,777 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
761,464 | $251,945,590 | |
| 4 | INCY |
Incyte Corp
|
1,264,195 | $118,986,027 | |
| 5 | RPRX |
Royalty Pharma plc
|
2,453,303 | $117,684,942 | |
| 6 | ARGX |
Argenx SE
|
139,381 | $101,782,972 | |
| 7 | INSM |
INSMED Inc
|
562,474 | $91,975,745 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
306,111 | $61,115,059 |
All Filings in SYRE
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,518,966 | 129,242 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $3,994,786 | 121,941 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $645,980 | 38,543 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $508,051 | 33,938 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $459,573 | 28,483 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $731,411 | 31,418 | Shares | Defined | 2025-06-30 | |
| 2024-09-30 | $632,550 | 21,508 | Shares | Defined | 2025-06-26 | |
| 2024-06-30 | $381,919 | 16,245 | Shares | Defined | 2025-06-12 | |
| 2024-03-31 | $11,303 | 298 | Shares | Defined | 2025-06-02 | |
| No filing history on record for this holder in this stock. | ||||||